Sex differences in HIV-1 viral load and progression to AIDS

Lancet

Volumn 352, Issue 9139, 1998, Pages 1510-1514

  Farzadegan, Homayoon ^a,b   Hoover, Donald R ^a   Astemborski, Jacqueline ^a   Lyles, Cynthia M ^a   Margolick, Joseph B ^a   Markham, Richard B ^a,b   Quinn, Thomas C ^a,b,c,d   Vlahov, David ^a,b  

^a Department of Epidemiology ^*  (Canada)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; VIRUS CULTURE; VIRUS LOAD;

EID: 0032494777     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)02372-1     Document Type: Article

References (18)

1. 1 Mellors JW, Muñoz A, Giorgi JV, et al. Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946-54.
2. 2 Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society - USA panel. JAMA 1997; 277: 1962-69.
3. 3 Panel on Clinical Practices for Treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV infected adults and adolescents. Bethesda, MD: US Department of Health and Human Services, 1997.
4. 4 Vlahov D, Graham NMH, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plams viral load and CD4 cell count. JAMA 1998; 279: 35-40.
5. 5 Galai N, Vlahov D, Margolick JB, Chen K, Graham NMH, Muñoz A. Changes in markers of disease progression in HIV-1 seroconverters: a comparision between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 66-74.
6. 6 Pezzoti P, Phillips AN, Dorrucci M, et al, for the HIV Italian Seroconversion Study Group. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. BMJ 1996; 313: 583-86.
7. 7 Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside analogue therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter: AIDS Clinical Trials Group Study 175 Virologic Study. N Engl J Med 1996; 335: 1091-98.
8. 8 Bush CE, Donovan RM, Markowitz N, Baxa D, Kvale P, Saravolatz LD. Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia. J Clin Microbiol 1996; 34: 970-72.
9. 9 Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection among intravenous drug users: description of methods. J Drug Issu 1991; 21: 767-79.
10. 10 Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41 (Rr-17): 1-19.
11. 11 Giorgi JV, Cheng HL, Margolick JB, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets the multicenter AIDS cohort experience. Clin Immunol Immunopathol 1990; 55: 173-86.
12. 12 Myers LE, McQuay LJ, Hollinger FB. Dilution assay statistics. J Clin Microbiol 1994; 32: 732-39.
13. 13 Hessol NA, Palacio H. Gender, ethnicity and transmission category variation in HIV progression. AIDS 1996; 10 (suppl A): S69-74.
14. 14 Brancato G, Perucci CA, Abeni DC, Sangalli M, Ippolito ??, Area M. The changing distribution of HIV infection: HIV surveillance in Lazio, Italy. Am J Public Health 1997; 87: 1654-58.
15. 15 Petersen PK, Sharp BM, Gekker G, et al. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 1990; 4: 869.
16. 16 Petersen PK, Gekker G, Chao ??, et al. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures: involvement of transforming growth factor-β. J Immunol 1991; 146: 81.
17. 17 Mellors JW, Griffith BP, Ortiz MA, et al. Tumor necrosis factor alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 1991; 163: 78.
18. 18 Shanker G, Sorci-Thomas M, Adams MR. Estrogen modulates the expression of tumor necrosis factor alpha mRNA in phorbol ester-stimulated human monocytic THP-1 cells. Lymphokine Cytokine Res 1994; 13: 377-82.